---
layout: post
title: "Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products: Small Entity Compliance Guide; Availability"
date: 2026-02-05 19:01:21 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-23573
original_published: 2022-11-01 00:00:00 +0000
significance: 8.00
---

# Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products: Small Entity Compliance Guide; Availability

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** November 01, 2022 00:00 UTC
**Document Number:** 2022-23573

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance entitled "Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/ Ps): Small Entity Compliance Guide." The small entity compliance guide (SECG) is intended to help small entity establishments that manufacture HCT/Ps better understand the comprehensive regulatory framework for HCT/Ps set forth in the regulations and comply with certain HCT/P- related final rules. The SECG announced in this notice supersedes the SECG of the same title dated August 2007.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/11/01/2022-23573/regulation-of-human-cells-tissues-and-cellular-and-tissue-based-products-small-entity-compliance)
- API: https://www.federalregister.gov/api/v1/documents/2022-23573

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
